{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:06:07Z","timestamp":1779422767337,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"crossref","award":["031L0299H"],"award-info":[{"award-number":["031L0299H"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Helmholtz-Zentrum f\u00fcr Infektionsforschung GmbH (HZI)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic and related non-pharmaceutical interventions (NPIs) (e.g., lockdowns and contact restrictions) disrupted routine healthcare delivery. In Germany, these measures affected diagnostic and treatment services for people with cancer and cardiovascular diseases, potentially delaying diagnosis and adversely influencing outcomes. We assessed whether and to what extent diagnosis, health utilization and health outcome among patients with selected cancer and cardiovascular conditions changed in Germany during the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted two systematic reviews of studies from Germany on selected cancers (breast, lung and pancreatic) and cardiovascular conditions (atrial fibrillation\/flutter, heart failure, hypertensive and chronic ischemic heart disease). Protocols were registered in PROSPERO and the reviews were reported in accordance with PRISMA. We searched PubMed, Web of Science, Cochrane Library, Scopus, and Embase and screened grey literature. Outcomes included changes in new diagnoses, healthcare utilization, treatment, and disease-specific mortality during the pandemic (2020\u20132023) compared with the pre-pandemic period (2018\u20132019). Two reviewers independently screened records, extracted data, and assessed risk of bias using an adapted ROBINS-E tool. Owing to heterogeneity, we synthesized findings narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We screened 1991 records for cancer and 4,981 records for cardiovascular diseases, and included 9 cancer studies and 10 cardiovascular studies. For cancer, several studies reported a relative reduction in new breast and lung cancer diagnoses of up to 25% during lockdown periods; hospital admissions decreased by up to 9%. For cardiovascular conditions, hospital admissions for atrial fibrillation\/flutter and heart failure decreased by up to 20%, particularly during pandemic peaks. Evidence on treatment delays, changes in treatment, and mortality was limited, and outcomes for other included diagnoses were often not reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The available evidence indicates substantial reductions in hospital admissions and new diagnoses among patients with cancer and cardiovascular disease in Germany during the pandemic, suggesting major disruptions to care delivery. However, heterogeneity and gaps in the evidence base limit a comprehensive assessment of downstream outcomes. More comprehensive, linked data and further research are needed to quantify the full pandemic\u2019s impact and to strengthen health-system resilience for future crises.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-026-03192-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:59:30Z","timestamp":1779418770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of the COVID-19 pandemic on diagnosis, and healthcare utilization, among patients with cancer (lung, breast, and pancreas) and cardiovascular diseases (HF, AF, hypertensive, and chronic ischemic heart disease) in Germany: two systematic reviews"],"prefix":"10.1186","volume":"15","author":[{"given":"Janine","family":"Ropeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Overhageb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Dreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6rthe","family":"Meyerdierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Heinsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina J.","family":"Klett-Tammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-0103","authenticated-orcid":false,"given":"Manuela","family":"Harries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"7889","key":"3192_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-021-04188-6","volume":"600","author":"J Li","year":"2021","unstructured":"Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600(7889):408\u201318.","journal-title":"Nature"},{"issue":"11","key":"3192_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260371","volume":"16","author":"S Iezadi","year":"2021","unstructured":"Iezadi S, Gholipour K, Azami-Aghdash S, Ghiasi A, Rezapour A, Pourasghari H, et al. Effectiveness of non-pharmaceutical public health interventions against COVID-19: A systematic review and meta-analysis. PLoS ONE. 2021;16(11):e0260371.","journal-title":"PLoS ONE"},{"key":"3192_CR3","unstructured":"Federal Government. Measures by the Federal Government to contain the spread of the COVID-19 pandemic abd address its impacts.pdf>: Federal Government; 2020 [https:\/\/www.bundesregierung.de\/resource\/blob\/974430\/1753912\/8e7d1b394d9508c2856f7b7b0a253352\/2020-05-18-massnahmen-englisch-data.pdf?download=1."},{"issue":"Suppl 10","key":"3192_CR4","first-page":"1","volume":"5","author":"Robert Koch-Institut","year":"2020","unstructured":"Robert Koch-Institut. Care for the chronically ill in Germany - The challenges during the COVID-19 pandemic. J Health Monit. 2020;5(Suppl 10):1\u201328.","journal-title":"J Health Monit"},{"issue":"1","key":"3192_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10654-022-00946-6","volume":"38","author":"M Angelini","year":"2023","unstructured":"Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P. Decrease of cancer diagnosis during COVID-19 pandemic: A systematic review and meta-analysis. Eur J Epidemiol. 2023;38(1):31\u20138.","journal-title":"Eur J Epidemiol"},{"key":"3192_CR6","doi-asserted-by":"crossref","unstructured":"Khan MZ, Badruddeen, Khushtar M, Akhtar J, Khan MI, Ahmad M, Chand I. A Systematic Review of COVID-19 Impact on Cardiovascular Diseases. Coronaviruses. 2023;4(2):4\u201316.","DOI":"10.2174\/2666796704666230608121558"},{"key":"3192_CR7","unstructured":"Federal health reporting. Gesundheitliche Lage. Mortalit\u00e4t und Todesursachen 2025 [https:\/\/www.gbe-bund.de\/gbe\/isgbe.fundstellen?p_uid=gast&p_aid=10353405&p_sprache=D&p_thema_id=3900&p_action=TRT#wrap."},{"issue":"1","key":"3192_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s44263-025-00143-z","volume":"3","author":"KR Moran","year":"2025","unstructured":"Moran KR, Lopez T, Del Valle SY. The future of pandemic modeling in support of decision making: Lessons learned from COVID-19. BMC Glob Public Health. 2025;3(1):24.","journal-title":"BMC Glob Public Health"},{"key":"3192_CR9","unstructured":"Robert Koch-Institut. Public Health - Health for all 2025 [updated 04.08.2025. https:\/\/www.rki.de\/DE\/Home\/home_node.html."},{"key":"3192_CR10","unstructured":"Veritas Health Innovation. Covidence systematic review software Melbourne, Australia [https:\/\/www.covidence.org\/."},{"key":"3192_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108602","volume":"186","author":"JPT Higgins","year":"2024","unstructured":"Higgins JPT, Morgan RL, Rooney AA, Taylor KW, Thayer KA, Silva RA, et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int. 2024;186:108602.","journal-title":"Environ Int"},{"key":"3192_CR12","unstructured":"Kraywinkel K, Imhoff M, Voigtlaender S, Stang A. Cancer incidence in pandemic times. Results from German Cancer Registries for the Diagnostic Year 2020. Onkologie. 2023."},{"issue":"3","key":"3192_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00404-021-06211-7","volume":"305","author":"T Kaltofen","year":"2022","unstructured":"Kaltofen T, Hagemann F, Harbeck N, Wuerstlein R, Kost BP, Burges A, et al. Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: Analysis from a tertiary academic gyneco-oncological center in Germany. Arch Gynecol Obstet. 2022;305(3):713\u20138.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"3192_CR14","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00432-022-04044-8","volume":"149","author":"S Griewing","year":"2023","unstructured":"Griewing S, Wagner U, Lingenfelder M, Fischer R, Kalder M. Chronological development of in-patient oncology in times of COVID-19: A retrospective analysis of hospitalized oncology and COVID-19 patients of a German University Hospital. J Cancer Res Clin Oncol. 2023;149(6):2551\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"3192_CR15","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00432-022-03922-5","volume":"148","author":"L Jacob","year":"2022","unstructured":"Jacob L, Kalder M, Kostev K. Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany. J Cancer Res Clin Oncol. 2022;148(11):3117\u201323.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"3192_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000512935","volume":"44","author":"P Reichardt","year":"2021","unstructured":"Reichardt P, Bollmann A, Hohenstein S, Glass B, Untch M, Reichardt A, et al. Decreased incidence of oncology admissions in 75 Helios Hospitals in Germany during the COVID-19 pandemic. Oncol Res Treat. 2021;44(3):71\u20135.","journal-title":"Oncol Res Treat"},{"key":"3192_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030408","author":"L Jacob","year":"2021","unstructured":"Jacob L, Loosen SH, Kalder M, Luedde T, Roderburg C, Kostev K. Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13030408.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3192_CR18","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.1007\/s00432-023-04707-0","volume":"149","author":"S Voigtl\u00e4nder","year":"2023","unstructured":"Voigtl\u00e4nder S, Hakimhashemi A, Grundmann N, Radespiel-Tr\u00f6ger M, Inwald EC, Ortmann O, et al. Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol. 2023;149(10):7493\u2013503.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"3192_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.21037\/jtd-22-1091","volume":"15","author":"IB Metelmann","year":"2023","unstructured":"Metelmann IB, Kraemer S, Steinert M, Kersting S, Busemann A. Narrowing the therapeutic window?\u2014A case-control study on the influence of the COVID-19 pandemic on the primary UICC stage of NSCLC. J Thorac Dis. 2023;15(3):1106\u201314.","journal-title":"J Thorac Dis"},{"key":"3192_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.594117","volume":"8","author":"LA Kapsner","year":"2020","unstructured":"Kapsner LA, Kampf MO, Seuchter SA, Gruendner J, Gulden C, Mate S, et al. Reduced rate of inpatient hospital admissions in 18 German university hospitals during the COVID-19 lockdown. Front Public Health. 2020;8:594117.","journal-title":"Front Public Health"},{"issue":"11","key":"3192_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2021-211183","volume":"38","author":"A Bollmann","year":"2021","unstructured":"Bollmann A, Hohenstein S, Pellissier V, K\u00f6nig S, Ueberham L, Hindricks G, et al. Hospitalisations for emergency-sensitive conditions in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network. Emerg Med J. 2021;38(11):846.","journal-title":"Emerg Med J"},{"issue":"3","key":"3192_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/ehjqcco\/qcaa049","volume":"6","author":"A Bollmann","year":"2020","unstructured":"Bollmann A, Hohenstein S, Meier-Hellmann A, Kuhlen R, Hindricks G. Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network. Eur Heart J Qual Care Clin Outcomes. 2020;6(3):221\u20132.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"3192_CR23","doi-asserted-by":"crossref","unstructured":"Jaehn P, Holmberg C, Uhlenbrock G, Pohl A, Finkenzeller T, Pawlik MT, Quack I, Ernstberger A, Rockmann F, Schreyer AG. Differential trends of admissions in accident and emergency departments during the COVID-19 pandemic in Germany.\u00a0BMC emergency medicine, 2021;21(1):42.","DOI":"10.1186\/s12873-021-00436-0"},{"issue":"1","key":"3192_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/clc.23762","volume":"45","author":"S K\u00f6nig","year":"2022","unstructured":"K\u00f6nig S, Pellissier V, Leiner J, Hohenstein S, Ueberham L, Meier\u2010Hellmann A, et al. Expected and observed in\u2010hospital mortality in heart failure patients before and during the COVID\u201019 pandemic: introduction of the machine learning\u2010based standardized mortality ratio at Helios hospitals. Clinical cardiology (Mahwah, NJ). 2022;45(1):75\u201382.","journal-title":"Clinical cardiology (Mahwah, NJ)"},{"issue":"10","key":"3192_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02074-3","volume":"111","author":"A Slagman","year":"2022","unstructured":"Slagman A, Pigorsch M, Greiner F, Behringer W, Bernhard M, Bienzeisler J, et al. Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysis. Clin Res Cardiol. 2022;111(10):1174.","journal-title":"Clin Res Cardiol"},{"key":"3192_CR26","doi-asserted-by":"crossref","unstructured":"St\u00f6hr E, Aksoy A, Campbell M, Al Zaidi M, \u00d6zt\u00fcrk C, Vorloeper J, Lange J, Sugiura A, Wilde N, Becher MU, Diepenseifen C, Heister U, Nickenig G, Zimmer S, Tiyerili V. Hospital admissions during Covid-19 lock-down in Germany: differences in discretionary and unavoidable cardiovascular events. PLoS One. 2020;15(11):e0242653.","DOI":"10.1371\/journal.pone.0242653"},{"issue":"4","key":"3192_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/a-1384-0508","volume":"83","author":"M St\u00f6whas","year":"2021","unstructured":"St\u00f6whas M, Lippert H. Entwicklung der Notaufnahmezahlen eines Schwerpunktversorgers im Verlauf der Corona-Pandemie in Mecklenburg-Vorpommern<br>. Gesundheitswesen. 2021;83(4):265\u201373.","journal-title":"Gesundheitswesen"},{"issue":"3","key":"3192_CR28","volume":"7","author":"L Ueberham","year":"2021","unstructured":"Ueberham L, K\u00f6nig S, Pellissier V, Hohenstein S, Meier-Hellmann A, Kuhlen R, et al. Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic\u2014insights from the German-wide Helios hospital network. Eur Heart J. 2021;7(3):257.","journal-title":"Eur Heart J"},{"key":"3192_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.zefq.2022.05.007","volume":"173","author":"K Bestehorn","year":"2022","unstructured":"Bestehorn K, Schwaab B, Schlitt A. Wie stark hat die COVID-19-Pandemie die kardiologische Rehabilitation im ersten Jahr der Pandemie beeinflusst? Ein Vergleich der Leistungszahlen aus 2019 mit 2020 in Deutschland. Z Evid Fortbild Qual Gesundhw. 2022;173:22.","journal-title":"Z Evid Fortbild Qual Gesundhw"},{"key":"3192_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100778","author":"F Kerwagen","year":"2023","unstructured":"Kerwagen F, Riemer U, Wachter R, Von Haehling S, Abdin A, B\u00f6hm M, et al. Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis. The Lancet Regional Health. 2023. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100778.","journal-title":"The Lancet Regional Health"},{"issue":"12","key":"3192_CR31","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3192_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in Atrial Fibrillation using a novel risk factor-based approach. The Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"82","key":"3192_CR33","first-page":"644","volume":"6","author":"EC Inwald","year":"2022","unstructured":"Inwald EC, et al. Influence of the COVID-19 Pandemic on the Incidence, Stage Distribution and Therapies of Cancer. Geburtshilfe Frauenheilkd. 2022;6(82):644.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"3192_CR34","doi-asserted-by":"crossref","unstructured":"Seidu S, Kunutsor SK, Cos X, Khunti K. Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: a systematic review. Elsevier BV; 2021. p. 653.","DOI":"10.21203\/rs.3.rs-501010\/v1"},{"key":"3192_CR35","doi-asserted-by":"crossref","unstructured":"Khan Y, Verhaeghe N, Devleesschauwer B, Cavillot L, Gadeyne S, Pauwels N. S, VAn den Borre L. & De Smedt, D. Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review. TheLancet. 2023;402:S61.","DOI":"10.1016\/S0140-6736(23)02117-7"},{"issue":"7","key":"3192_CR36","first-page":"647","volume":"9","author":"Y Khan","year":"2023","unstructured":"Khan Y, Verhaeghe N, Devleesschauwer B, Cavillot L, Gadeyne S, Pauwels N, et al. The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review. Eur Heart J. 2023;9(7):647.","journal-title":"Eur Heart J"},{"issue":"08","key":"3192_CR37","first-page":"2023","volume":"17","author":"G Bundesausschuss","year":"2023","unstructured":"Bundesausschuss G. Dapagliflozin (Neues Anwendungsgebiet: chronische Herzinsuffizienz mit linksventrikul\u00e4rer Ejektionsfraktion LVEF > 40 %). Beschluss vom. 2023;17(08):2023.","journal-title":"Beschluss vom"},{"key":"3192_CR38","unstructured":"Gemeinsamer Bundesausschuss. Zusammenfassende Dokumentation \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII \u2013 Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach \u00a7 35a des F\u00fcnften Buches Sozialgesetzbuch (SGB V): Sacubitril\/Valsartan (Neues Anwendungsgebiet: chronische Herzinsuffizienz mit linksventrikul\u00e4rer Dysfunktion, 1 Jahr bis 17 Jahre). 2023."},{"key":"3192_CR39","doi-asserted-by":"crossref","unstructured":"Ghisi GLDM, Xu Z, Liu X, Mola A, Gallagher R, Babu AS, Yeung C, Marzolini S, Buckley J, Oh P, Contractor A, Grace SL. Impacts of the COVID-19 pandemic on cardiac rehabilitation delivery around the world. Global Heart. 2021;16(1):Artikel 23, S. 1\u201316.","DOI":"10.5334\/gh.939"},{"issue":"33","key":"3192_CR40","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1093\/eurheartj\/ehac227","volume":"43","author":"R Nadarajah","year":"2022","unstructured":"Nadarajah R, Wu J, Hurdus B, Asma S, Bhatt DL, Biondi-Zoccai G, et al. The collateral damage of COVID-19 to cardiovascular services: a meta-analysis. Eur Heart J. 2022;43(33):3164\u201378.","journal-title":"Eur Heart J"},{"issue":"1","key":"3192_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13102-022-00459-5","volume":"14","author":"R Kirwan","year":"2022","unstructured":"Kirwan R, Perez De Heredia F, McCullough D, Butler T, Davies IG. Impact of COVID-19 lockdown restrictions on cardiac rehabilitation participation and behaviours in the United Kingdom. BMC Sports Sci Med Rehabil. 2022;14(1):1\u201311.","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"3192_CR42","unstructured":"Tuchel C. Digitale Therapien zur Rehabilitation und Nachsorge. 2024."},{"issue":"3","key":"3192_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00103-023-03665-9","volume":"66","author":"I Sch\u00e4fer","year":"2023","unstructured":"Sch\u00e4fer I, Haack A, Neumann M, Koch-Gromus U, Scherer M, Petersen E. Nichtinanspruchnahme medizinischer Leistungen in der COVID-19-Pandemie bei Personen mit chronischen Erkrankungen. Bundesgesundheitsblatt. 2023;66(3):275\u201382.","journal-title":"Bundesgesundheitsblatt"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03192-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03192-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03192-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:15:03Z","timestamp":1779419703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03192-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3192"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03192-z","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required. Not applicable\u2014no participants were involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u2014no personal data were published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}